Charles Schwab Investment Management Inc T2 Biosystems, Inc. Transaction History

Charles Schwab Investment Management Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$0.15 - $0.54 $25,514 - $91,851	170,096 New	170,096 $28,000
Q1 2022 May 13, 2022	SELL	$0.36 - $0.57 $17,105 - $27,083	-47,515 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$0.48 - $1.67 $22,807 - $79,350	47,515 New	47,515 $61,000
Q2 2019 Aug 09, 2019	SELL	$1.47 - $3.16 $100,647 - $216,358	-68,468 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$5.36 - $7.83 $59,924 - $87,539	11,180 Added 19.52%	68,468 $511,000
Q2 2018 Aug 08, 2018	BUY	$5.97 - $9.58 $342,009 - $548,819	57,288 New	57,288 $444,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $15.9M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Charles Schwab Investment Management Inc with notifications on news.